Peg-filgrastim and cabazitaxel in prostate cancer patients.

Peg-filgrastim and cabazitaxel in prostate cancer patients.

Item
http://www.wikidata.org/entity/Q38050328
Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerCabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program.Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall SurvivalPegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature.Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports.
P2860

Peg-filgrastim and cabazitaxel in prostate cancer patients.

Item
http://www.wikidata.org/entity/Q38050328
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Peg-filgrastim and cabazitaxel in prostate cancer patients.
@en
type
label
Peg-filgrastim and cabazitaxel in prostate cancer patients.
@en
prefLabel
Peg-filgrastim and cabazitaxel in prostate cancer patients.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Peg-filgrastim and cabazitaxel in prostate cancer patients
@en
P2093
P304
P31
P356
10.1097/CAD.0B013E32835A56BC
P433
P478
P50
P577
P698